Skip to main content
Al Hammadi Holding logo

Al Hammadi Holding — Investor Relations & Filings

Ticker · 4007 ISIN · SA13J051UJH4 Saudi Exchange Human health and social work activities
Open in API
Filings indexed 235 across all filing types
Latest filing 2021-11-11 Notice of Dividend Amou…
Country SA Saudi Arabia
Listing Saudi Exchange 4007

About Al Hammadi Holding

http://www.alhammadi.com

Al Hammadi Holding specializes in the establishment, management, and operation of comprehensive medical facilities and hospitals. The organization provides a broad spectrum of healthcare services, including inpatient and outpatient care, specialized surgical interventions, diagnostic imaging, and laboratory services. Its operational scope extends to the wholesale and retail distribution of pharmaceuticals, medical equipment, and clinical supplies. The company focuses on maintaining advanced medical infrastructure and integrating modern healthcare technologies to support diverse patient needs. Additionally, it engages in medical maintenance and the procurement of healthcare-related products, ensuring a vertically integrated approach to medical service delivery and facility management.

Recent filings

Filing Released Lang Actions
Al Hammadi Company for Development and Investment announces the distribution of cash dividend for 2021
Notice of Dividend Amount Classification · 100% confidence The document is an announcement from Al Hammadi Company for Development and Investment regarding the distribution of cash dividends for the fiscal year 2021. It specifies the dividend amount, eligibility date, and that the distribution date will be announced later. The content focuses solely on dividend distribution details without including full financial statements or comprehensive report data. The document length is short (2223 characters) and it is clearly an announcement rather than a full report. Therefore, it fits the category of Notice of Dividend Amount (DIV).
2021-11-11 English
Al Hammadi Company for Development and Investment Announces the recommendation of the Board of Directors to distribute interim dividends, semi-annually or quarterly, to the Shareholders for the fiscal
Notice of Dividend Amount Classification · 95% confidence The document is an announcement from the Board of Directors recommending the distribution of interim dividends for the fiscal year 2022. It is a short announcement (1759 characters) and does not contain actual financial statements or detailed financial data. It specifically discusses dividend distribution recommendations, which aligns with the category for Notice of Dividend Amount. There is no indication that this is a full report or a certification, so it is not classified as a regulatory filing or report publication announcement. Therefore, the appropriate classification is Notice of Dividend Amount (DIV).
2021-11-11 English
Al Hammadi Company for Development and Investment Announces the Purchase of 35% of Sudair Pharmaceuticals in the value of 118,125,000 saudi riyals
Capital/Financing Update Classification · 95% confidence The document is an announcement by Al Hammadi Company for Development and Investment regarding the purchase of a 35% stake in Sudair Pharmaceuticals. It details the transaction value, terms, approvals, and expected impact on the company. There is no indication of this being a full financial report, audit, or earnings release. The content focuses on a capital acquisition transaction, including regulatory approvals and transaction details. This fits the definition of a Capital/Financing Update (CAP) as it relates to company fundraising and capital structure changes through acquisition.
2021-11-09 English
Al Hammadi Company for Development and Investment Announces the latest developments regarding the signing of an agreement to purchase 35% of Sudair Pharmaceutical Company
Capital/Financing Update Classification · 95% confidence The document is an announcement regarding the signing of an agreement to purchase 35% of Sudair Pharmaceutical Company. It mentions the decision by the General Authority for Competition and the intention to complete acquisition procedures. There are no financial statements, detailed financial data, or comprehensive report content. The document is short (1640 characters) and serves as an update on a capital transaction. This fits the definition of a Capital/Financing Update (CAP) rather than a full merger filing or detailed report.
2021-10-11 English
Addendum Announcement from Al Hammadi Company for Development and Investment in regards to signing an agreement to purchase 35% of Sudair Pharmaceutical Company
Capital/Financing Update Classification · 95% confidence The document is an announcement regarding an addendum to a previously disclosed agreement to purchase 35% of Sudair Pharmaceutical Company. It mentions extending the duration of the agreement and states there is no financial impact. The document is short (1724 characters) and serves as an update to a prior announcement rather than a full report or detailed financial disclosure. It does not contain financial statements, management discussion, or detailed financial data. Therefore, it fits best as a Capital/Financing Update (CAP) since it relates to a financing transaction update (purchase agreement extension).
2021-10-10 English
The Board of Directors of Al Hammadi Company for Development and Investment approved To construct a new hospital to replace the current Al Hammadi Hospital Olaya
Board/Management Information Classification · 95% confidence The document is an announcement from the Board of Directors regarding the approval of a new hospital construction project, including details on project cost, financing, expected impact on financial results, and timelines. It does not contain financial statements, detailed financial performance data, or regulatory filings such as annual or quarterly reports. The document is relatively short (3026 characters) and serves as a corporate announcement about a strategic project approval by the board. This fits best under Board/Management Information (MANG), which covers announcements of changes or decisions by the board of directors or senior management. There is no indication that this is a full report, earnings release, or regulatory filing. Therefore, the classification is MANG with high confidence.
2021-09-16 English

Browse filings by year

13 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.